Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

856 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA.
González-Gay MA, González-Juanatey C. González-Gay MA, et al. Nat Rev Rheumatol. 2012 Nov;8(11):641-2. doi: 10.1038/nrrheum.2012.158. Epub 2012 Sep 25. Nat Rev Rheumatol. 2012. PMID: 23007743 No abstract available.
Influence of HLA-DRB1 and TNF microsatellite polymorphisms on the expression of extraarticular manifestations in rheumatoid arthritis patients from northwest Spain.
Mattey DL, Gonzalez-Gay MA, Garcia-Porrua C, Thomson W, Hajeer AH, Ollier WE. Mattey DL, et al. Clin Exp Rheumatol. 2001 Nov-Dec;19(6):703-8. Clin Exp Rheumatol. 2001. PMID: 11791643
Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
González-Gay MA, Hajeer AH, García-Porrúa C, Dababneh A, Thomson W, Ollier WE, Mattey DL. González-Gay MA, et al. J Rheumatol. 2002 Feb;29(2):271-5. J Rheumatol. 2002. PMID: 11842822
Corticotropin-releasing hormone promoter polymorphisms in patients with rheumatoid arthritis from northwest Spain.
Gonzalez-Gay MA, Hajeer AH, Garcia-Porrua C, Dababneh A, Amoli MM, Botana MA, Thomson W, Llorca J, Ollier WE. Gonzalez-Gay MA, et al. J Rheumatol. 2003 May;30(5):913-7. J Rheumatol. 2003. PMID: 12734882
Rheumatoid arthritis and anti-TNF-alpha therapy.
Gonzalez-Juanatey C, Gonzalez-Gay MA. Gonzalez-Juanatey C, et al. Atherosclerosis. 2005 Jul;181(1):209. doi: 10.1016/j.atherosclerosis.2005.02.031. Atherosclerosis. 2005. PMID: 15899482 No abstract available.
High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis.
Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, Garcia-Porrua C, Testa A, Llorca J. Gonzalez-Gay MA, et al. J Rheumatol. 2005 Jul;32(7):1219-23. J Rheumatol. 2005. PMID: 15996055
Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis.
Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. Gonzalez-Juanatey C, et al. Arthritis Rheum. 2006 Feb 15;55(1):150-3. doi: 10.1002/art.21707. Arthritis Rheum. 2006. PMID: 16463428 Clinical Trial. No abstract available.
Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
Garcia-Porrua C, Gonzalez-Gay MA, Quevedo V. Garcia-Porrua C, et al. J Rheumatol. 2006 Feb;33(2):433; author reply 433-4. J Rheumatol. 2006. PMID: 16465676 No abstract available.
SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population.
Orozco G, Sánchez E, González-Gay MA, López-Nevot MA, Torres B, Pascual-Salcedo D, Balsa A, Pablos JL, García A, González-Escribano MF, Martín J. Orozco G, et al. J Rheumatol. 2006 Jul;33(7):1235-9. J Rheumatol. 2006. PMID: 16821265
Cardiovascular disease in rheumatoid arthritis.
Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Garcia-Porrua C, Llorca J, Martin J. Gonzalez-Gay MA, et al. Biomed Pharmacother. 2006 Dec;60(10):673-7. doi: 10.1016/j.biopha.2006.09.006. Epub 2006 Oct 10. Biomed Pharmacother. 2006. PMID: 17049201 Review.
856 results
Jump to page